+924.9%
MRNA vs CHYM
+63.9%
+860.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CHYM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.5% | +1.0% | -7.6% | -6.9% |
| 7D | +8.4% | +4.5% | +3.9% | +6.7% |
| 30D | +28.8% | +9.2% | +19.7% | +25.3% |
| 3M | +329.2% | +16.4% | +312.8% | +318.0% |
| 6M | +416.9% | +45.2% | +371.8% | +369.8% |
| YTD | +718.8% | +19.9% | +698.9% | +646.7% |
| 1Y | +924.9% | +57.8% | +867.0% | +791.2% |
| All | +924.9% | +63.9% | +860.9% | +791.2% |
Cumulative growth
Daily Returns
Daily percentage return beside CHYM.
Daily Out/Under-Performance
Portfolio return minus CHYM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CHYM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CHYM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling